ACS Global, Inc.
OTC: AMCY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Anthony Francis Dudzinski Jr.
- Headquarters
- Red Bank, United States
- IPO year
- 2021
- Market cap
- $171.3M
- Website
- https://www.americancryostem.com
Loading AMCY…
Loading profile data…Frequently asked questions about AMCY
What does ACS Global, Inc. (AMCY) do?
ACS Global, Inc. specializes in the acquisition, meticulous processing, and secure, long-term cryogenic storage of stem cells. The company enables individuals to privately bank their own stem cells for potential future applications in cellular therapy. Headquartered in Red Bank, New Jersey, the firm adopted its current name, ACS Global, Inc., in...
Where does AMCY trade?
ACS Global, Inc. (AMCY) trades on the Other OTC.
What sector is AMCY in?
ACS Global, Inc. (AMCY) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of ACS Global, Inc.?
Anthony Francis Dudzinski Jr. is the chief executive officer of ACS Global, Inc. (AMCY).
Where is ACS Global, Inc. headquartered?
ACS Global, Inc. is headquartered in United States.
Does AMCY pay a dividend?
ACS Global, Inc. (AMCY) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AMCY go public?
ACS Global, Inc. (AMCY) completed its initial public offering in 2021.